Dow Up 0.35% Nasdaq Down 0.02%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
13.65 Down 0.49(3.47%) 4:00PM EDT
|After Hours : 14.12 Up 0.47 (3.42%) 4:46PM EDT
Prev Close:14.14
Open:14.02
Bid:13.68 x 200
Ask:13.84 x 1000
1y Target Est:26.00
Beta:1.21
Earnings Date:Oct 21 - Oct 27 (Est.)
Day's Range:13.60 - 14.16
52wk Range:8.93 - 24.69
Volume:567,214
Avg Vol (3m):806,486
Market Cap:930.44M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SGMO

Comparison

Symbol% ChgMkt Cap
SGMODown 3.47%930.44M
AMGNDown 0.26%100.78B
LLYDown 0.24%66.46B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback